Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL946122 | 0.87 | — | — | |
| SCHEMBL945102 | 0.85 | — | — | |
| SCHEMBL945667 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL4241154 | 0.62 | CYP19A1 (0.34) | — | |
| SCHEMBL18261167 | 0.62 | TSHR (0.36) | — | |
| SCHEMBL944815 | 0.61 | CYP19A1 (0.34) | — | |
| SCHEMBL27499468 | 0.61 | — | — | |
| SCHEMBL5006653 | 0.59 | NPC1 (0.35) | KIF11 | |
| SCHEMBL5009438 | 0.59 | NPC1 (0.31) | — | |
| SCHEMBL21407054 | 0.59 | ACHE (0.33) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110003953-A1 | Carbon-Bridged Cyclopentadienyl-Fluorenyl Ligands | FINA TECHNOLOGY, INC. (US) | 2011-01-06 | — | — | US | disclosed |
| EP-1734059-A1 | Carbon-bridged cyclopentadienyl-fluorenyl ligands | TOTAL PETROCHEMICALS RESEARCH FELUY (BE) | 2006-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110003953-A1 | Carbon-Bridged Cyclopentadienyl-Fluorenyl Ligands | CCR3, CNOT9, MYCBP | KIF11 549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.